FDA.reportPublic FDA data

NDC 50090-0701-00 - Doxazosin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
50090-0701
Requested NDC
50090-0701-00
Package NDCs from labels
50090-0701-0, 50090-0701-00
Manufacturer
A-S Medication Solutions
Effective date
2026-10-06
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Doxazosin - A-S Medication SolutionsA-S Medication Solutions2026-10-06HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
EffectiveRelated label
2023-02-07These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
2023-02-07These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
2023-02-07These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
2023-01-30These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
2023-01-30These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
2023-01-30These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-0701-0Doxazosin30 in 1 BOTTLETABLET3030

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-0701DOXAZOSIN TABLET [A-S MEDICATION SOLUTIONS]28Current NDC, Legacy NDC, 1 package rows20240615_bfea0b5b-9354-490f-88ff-008134077d24.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-0701-0EA - Each50090-0701fc58bb48-b4d3-469e-a666-89182184246912018-10-11

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 4 · 68 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DoxazosinDOXAZOSINNorthwind Health Company, LLCf306adae-a2fe-5477-e053-2995a90a78382026-01-01Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197625
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEA-S Medication Solutions7aeaa0e1-136c-444d-b66c-7a5a96fb30222025-12-05Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
Doxazosin mesylateDOXAZOSIN MESYLATEAphena Pharma Solutions - Tennessee, LLC445dc831-1960-4b25-e063-6294a90a6efd2025-11-24Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEUpsher-Smith laboratories, LLCb5d1c604-ce3b-4973-845f-9db267a945cd2025-11-12Warnings, Adverse reactionsExact identifier
rxcui: 197625
rxcui: 197628
rxcui: 197626
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEBryant Ranch Prepackd42d2691-f25d-4dfc-99d0-3286d71480a42025-10-13Warnings, Adverse reactionsExact identifier
rxcui: 197625
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEA-S Medication Solutions57f4a953-ad23-4a44-9956-c48aa59271322025-10-02Warnings, Adverse reactionsExact identifier
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINAmerican Health Packaging3f4dc1a7-05e6-41d7-908c-30ce2677d87b2025-09-17Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197625
rxcui: 197626
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEA-S Medication Solutionsb4c974ad-cbd6-4811-ab48-461e7ffa99f72025-09-17Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINAphena Pharma Solutions - Tennessee, LLC3ab222b7-74cc-5343-e063-6294a90a96162025-07-24Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINNuCare Pharmaceuticals, Inc.30b709d6-c438-c721-e063-6294a90abd612025-03-19Warnings, Adverse reactionsExact identifier
rxcui: 197626
unii: 86P6PQK0MU
YVTYVT MICRODERMABRASION FACIAL SCRUBYVTYVT MICRODERMABRASION FACIAL SCRUBBeijing JUNGE Technology Co., Ltd.2f30fc45-42e2-c766-e063-6394a90a8d682025-02-28WarningsExact identifier
unii: OP1R32D61U
DoxazosinDOXAZOSINAphena Pharma Solutions - Tennessee, LLC2e5cd8cb-7d43-e7af-e063-6294a90a310e2025-02-17Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197628
unii: 86P6PQK0MU
DOXAZOSINDOXAZOSINdirect rxb57cf33b-e0bd-54e9-e053-2a95a90a5a6a2025-01-17Warnings, Adverse reactionsExact identifier
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINNuCare Pharmaceuticals,Inc.88efdfb0-710f-768a-e053-2995a90aede42024-12-17Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINZydus Lifesciences Limitedac889877-133c-4448-af5a-d77b3cbfe8782024-11-28Exact identifier
rxcui: 197625
rxcui: 197628
rxcui: 197626
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEA-S Medication Solutions9b6170e7-814a-46ef-b068-cf3e6508d5e12024-10-21Warnings, Adverse reactionsExact identifier
rxcui: 197628
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEAurobindo Pharma Limited93f2d724-5a54-4721-b04a-e46bc764607b2024-09-06Warnings, Adverse reactionsExact identifier
rxcui: 197625
rxcui: 197628
rxcui: 197626
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINBryant Ranch Prepack8c0c0345-833b-4a3d-9081-da66b208d7502024-09-05Warnings, Adverse reactionsExact identifier
rxcui: 197625
unii: 86P6PQK0MU
DoxazosinDOXAZOSINBryant Ranch Prepackef8b5534-5939-400a-ad5e-f9ceaefc40972024-09-05Warnings, Adverse reactionsExact identifier
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINBryant Ranch Prepackac4cd22b-2a03-47b6-9eed-550be278f17d2024-09-05Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.